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Background: The relationship between Type D personality and health related quality of life (HRQoL) in coronary
artery disease patients is becoming more established, however, the factors that may explain this association remain
unclear. The objective of the study was to examine the mediating effects of mental distress and social support on
the relationship between the Type D personality and HRQoL in CAD patients with heart failure.
Methods: A total of 855 CAD patients with heart failure were assessed on Type D personality, mental distress,
perceived social support and HRQoL with the following self-administered questionnaires: the Type D personality
scale - 14, the Hospital Anxiety and Depression scale, the Multidimensional Scale of Perceived Social Support and
the Minnesota Living with Heart Failure Questionnaire.
Results: The prevalence of Type D personality within the study population was 33.5%. Type D personality, anxiety
symptoms, depressive symptoms and social support were all found to be determinants of decreased HRQoL
(p’s < 0.001), once age, gender, NYHA functional class and acute myocardial infarction were adjusted for. Anxiety,
depressive symptoms and social support were found to mediate the relationship between Type D personality and
HRQoL. Type D personality exerted a stable effect on HRQoL over 24 months follow-up period.
Conclusions: Type D personality has an independent significant effect on the HRQoL in CAD patients with heart
failure, and this relation is mediated by anxiety and depressive symptoms, social support.
Keywords: Type D personality, Anxiety depression, Social support, Health-related quality of life, Coronary artery diseaseBackground
Coronary artery disease (CAD) remains a major public
health problem [1] and is a major contributor to the pro-
gression of heart failure [2]. Approximately 1–2% of the
adult population in developed countries suffers from heart
failure, with prevalence rates rising to ≥10% among per-
sons 70 years of age or older [3]. The overall prevalence of
heart failure is increasing because of the ageing of the
population, the success in prolonging survival in patients
suffering coronary events, and the success in postponing
acute coronary events by effective prevention in those at* Correspondence: julius.burkauskas@lsmuni.lt
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unless otherwise stated.high risk [4]. Heart failure patients experience high levels
of physical, functional and emotional distress, which has a
major impact on the health-related quality of life (HRQoL)
[5]. In an extensive research of both patients with CAD
and patients with heart failure HRQoL was shown to be
associated with disease severity [6,7], social support [8,9]
and psychological factors, including symptoms of mental
distress [10,11]. Moreover, more recent studies have re-
ported that a Type D personality may present as chronic
psychological risk factor among cardiac patients [12].
A distressed personality Type D profile is a vulnerability
factor for general psychological distress that affects mental
and physical health status [13]. Type D personality is char-
acterized by a joint manifestation of negative affectivityl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ant determinant of outcomes in cardiac patients. Type D
personality has a deleterious effect on the prognosis of pa-
tients with CAD. For example, Type D patients had a two-
fold increased risk of mortality and nonfatal myocardial
infarction (MI) [14,15]. Type D personality is also a pre-
dictor of poor health status in patients with established
CAD and heart failure. For example, type D personality
has been linked to poor HRQoL in CAD patients under-
going cardiac rehabilitation [16], as well as in chronic
heart failure patients [14]. In a prospective study, CAD pa-
tients with Type D personality were at a two-fold (OR =
2.2; 95% CI: 1.2–3.8) increased risk for reporting poor per-
ceived health at 5-year follow-up when compared with
non-Type D CAD patients [17].
Type D personality trait is associated with numerous ad-
verse behavioral and biological traits that can predispose
towards progression of heart failure and worse patient
outcomes [18]. For example, it has been demonstrated in
patients with established heart failure, that Type D per-
sonality is associated increased risk for poor treatment ad-
herence [19] and greater serum inflammatory marker
concentrations [20].
Type D personality is defined as having a high score
on two stable personality traits, negative affectivity and
social inhibition [21,22]. Inhibited individuals are more
vulnerable for developing anxiety and therefore Type D
personality patients are at risk to experience increased
levels of anxiety symptoms [23]. In heart failure patients,
Type D personality, but not depressive symptoms pre-
dicted clinically significant anxiety at 1-year follow-up.
These findings suggest that assessment of type D status
could be used to identify heart failure patients at high
risk for future anxiety that can subsequently contribute
towards impaired quality of life [23].
Type D personality patients experience increased levels
of depressive symptoms [24,25]. For example, in one-year
follow-up study of heart failure patients, Type D personal-
ity trait was independently associated with greater depres-
sive symptom severity [26]. It is well established that
depression is associated with adverse cardiac outcomes
such as increased mortality [27], decreased quality of life
[10,11] and is an independent risk factor in CAD [28].
Patients with Type D personality have a tendency to not
share emotions in social interactions, due to a fear of re-
jection or disapproval, and have a perceived lack of social
support. It was shown that CAD patients withType D per-
sonality, compared with non-Type D individuals, reported
less perceived social support. The influence of Type D
personality was apparent even controlling these finding
for anxiety and depression [29].
Social support is a known buffer of psychological dis-
tress and has also been shown to influence adverse med-
ical outcomes. Lack of social support is associated withincreased morbidity and mortality in patients with CAD
and heart failure [30-32] and with lower levels of HRQoL,
especially in women [9].
Although mental distress and lack of social support
are strongly related to Type D personality, it remains
unclear if these factors may mediate the association be-
tween Type D personality and HRQoL. Type D person-
ality is not a pathological condition in itself, rather it is a
normal personality disposition that is stable over a long
period of time [33]. Therefore, more research is neces-
sary to determine which factors may mediate the adverse
effects of Type D personality upon outcomes in cardiac
patients.
From a clinical perspective, it is important to know if
heart failure patients with Type D personality trait are at
greater risk for continuous deterioration/impairment in
their HRQoL, as this knowledge could potentially allow
for more accurate risk-stratification of heart failure pa-
tients admitted to rehabilitation program and provide
with an opportunity for early interventions aiming to ad-
dress behavioral/psychological risk factors in order to
improve patient prognosis.
The aim of this study was to evaluate the impact of
Type D personality upon HRQoL in CAD patients with
heart failure after acute coronary syndromes, both during
cardiac rehabilitation and during the two years follow-up.
Moreover, this study aimed, to examine the role of mental
distress and social support as psychosocial factors that




In a period from 2010 to 2013 a total of 962 consecutive
CAD patients attending an in-patient cardiac rehabilita-
tion program at the Cardiovascular Rehabilitation Clinic
of the Behavioral Medicine Institute of the Lithuanian
University of Health Sciences in Palanga, Lithuania were
invited to participate in this study. All study patients
were admitted to the rehabilitation program within one
week after treatment for acute coronary syndromes. Eli-
gible patients were those who had a clinical diagnosis of
heart failure, according to European Society of Cardiology
guidelines [34,35]. Study cardiologist (J.B.) evaluated pa-
tients’ symptoms of heart failure and objective evidence of
cardiac dysfunction assessed by echocardiography and in-
vited patients to participate. After agreeing to participate,
written informed consent (WIC) was given for evaluating
socio-demographic and clinical data and for using per-
sonal data (name, address and phone numbers) for follow
up assessment. Patients were excluded from the present
study if they had cognitive disorientation or communica-
tive disabilities (n = 51), had severe comorbidities (n = 18)
or unstable cardiovascular status (n = 28), were not willing
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sion criteria the study population comprised 855 (74%
men and 26% women; mean age, 58 ± 9 years) patients
with CAD. As we longitudinally observed patients’
HRQoL records, we had 30% (265 patients) overall attri-
tion leaving 650 patients after 6 months, 651 patients after
12 months, 648 patients after 18 months and 590 patients
after 24 months since the study started. The study proto-
col was approved by The Regional Medical Research Eth-
ics Committee.
Study design
The baseline measure was chosen to be patients’ assess-
ment within three days of admission to the rehabilitation
program after they signed WIC. During that time study
cardiologist evaluated patients demographic and clinical
characteristics. During the same time, patients without
presence of medical professionals in separate room in
the clinic filled-in questionnaires for assessment of Type
D personality [36], HRQoL [37], anxiety and depressive
symptoms [38] and perceived social support [39]. These
were validated Lithuanian versions of self-rating scales
[9,22,40]. HRQoL [37] was evaluated by qualified nurse
at baseline and after 6-, 12-, 18-, and 24-months follow-
up using telephone interview (Figure 1).
Measures
Socio-demographic and clinical characteristics
Age, sex and marital status (living alone, living with a
partner) were reported by patients during the initial
interview with study cardiologist.
Study cardiologist evaluated symptoms of heart failure
(at rest and during exercise test), objective evidence of
cardiac dysfunction (left ventricular systolic and/or dia-
stolic) and heart failure characteristics. The NYHA func-
tional classification system was used by the cardiologist
to classify the degree of functional disability based on
symptoms of fatigue, palpitation or dyspnea and activity
limitations [41]. NYHA Class I referring to no limitation,
Class II to slight limitation, Class III to marked limita-
tion in patient’s physical activity respectively. Class IV
represents patients who are unable to carry out any
physical activity without discomfort.
Left ventricular ejection fraction (LVEF) was assessed
by echocardiography and classified into: 1) LVEF ≤ 40% -
moderate to severe systolic dysfunction, 2) LVEF > 40% -
normal to mild systolic dysfunction. Patient’s history of
MI, acute MI, angina pectoris and hypertension were re-
trieved from the medical records.
Type D personality scale
Type D personality was measured with the Type D Per-
sonality Scale (DS14) validated in Lithuania [22]. The
DS14 consists of two 7-item subscales assessing negativeaffectivity (NA) and social inhibition (SI). Items on both
7-item scales are answered on a 5-point Likert scale
from “false” (0) to “true” (4) with scores ranging from 0
to 28 on each subscale. Scores equal or greater than 10
on both DS14 subscales of NA and SI indicate Type D
personality. Reliability of the scale is acceptable with
Cronbach’s alpha of 0.84/0.75 for the NA and SI
subscales.
Health-related quality of life scale
HRQoL was evaluated using the Minnesota Living with
Heart Failure Questionnaire (MLHFQ). MLHFQ is a
commonly used measure of HRQoL, specifically de-
signed for persons with heart failure. This questionnaire
consists of 21 questions covering physical, socioeco-
nomic and psychological dimensions of life, relative to
the limitations frequently associated with the profile of
cardiac insufficiency [37]. Items are answered on a 6-
point Likert scale from 0 (no) to 5 (very much). The
final score is the sum of the responses and varies from 0
(no impairment) to 105 (total impairment). The higher
scores reflect a decreased HRQoL. MLHFQ has ad-
equate internal reliability, Cronbach’s alpha coefficients
was 0.81.
Anxiety and depression symptoms scale
Anxiety and depressive symptoms were assessed using
the HADS. The HADS is a 14-item self-rating instru-
ment that consists of subscales of anxiety (HADS-A)
and depression (HADS-D), which are designed to meas-
ure respective symptoms. Each item is rated on a scale
from 0 to 3 based on the subject’s experience over the
past week. Total scores on the HADS-A and HADS-D
range from 0 to 21, with higher scores indicating more
severe anxiety and depression symptoms. Patients were
considered to have anxiety or depressive symptoms if
they scored ≥ 8 on the HADS-D or HADS-A [42]. The
Lithuanian version of the HADS has been shown to be
reliable screening instrument in Lithuanian CAD pa-
tients. In the current study, Cronbach’s coefficients alpha
of the HADS-A subscale was 0.84 and 0.75 for HADS-D
subscale, suggesting adequate internal consistency.
Perceived social support scale
Perceived social support was assessed using Multidi-
mensional Scale of Perceived Social Support (MSPSS).
The MSPSS assesses the perceived adequacy of social
support from family, friends and significant others as
rated by the patient [39]. The MSPSS is comprised of
12 items of social support scored on a seven-point
Likert-type scale ranging from “very strongly disagree”
to “very strongly agree”. For the purposes of this study,
only total score was calculated. For the total score, rat-
ings are summed and divided by 12. Total scores range
Consecutive CAD patients




cognitive disorientation or communicative
disabilities (n=51),
severe comorbidities (n=18),
unstable cardiovascular status (n=28),
unwilling to participate in the study (n=10).
ASSESSMENT duringin-patient cardiac rehabilitation program (N=855):
Type D personality (14 item Type D personality scale–DS-14),
Health related quality of life (Minnesota Living with Heart Failure
questionnaire, MLHFQ),
Anxiety and depressive symptoms (Hospital Anxiety and Depression scale,
HADS),
Perceived social support (Multidimensional perceived social support scale,
MPSS),
Evaluated for clinical and demographical characteristics.
ASSESSMENT after 6 months,
telephone interview (N=650):
MLHFQ
ASSESSMENT after 12 months,
telephone interview (N=651):
MLHFQ
ASSESSMENT after 18 months,
telephone interview (N=648):
MLHFQ
ASSESSMENT after 24 months,
telephone interview (N=590):
MLHFQ
Figure 1 Participant flow chart.
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perception of available social support. The MSPSS had
adequate internal reliability, with an alpha coefficient
of 0.88.Statistical analysis
Differences in clinical, demographic, mental distress
and HRQoL characteristics of patients, stratified by
Type D personality were tested using independent sample
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than 0.05 difference between proportions test.
Simple univariate regression analyses were conducted
to determine the relationship between HRQoL and gen-
der, age, acute MI, angina pectoris, LVEF, NYHA class,
hypertension, Type D, anxiety score, depression score,
and social support. A probability level of 0.05 or less was
used as the criterion to include the independent variable
in the multivariate models and a probability level of 0.1
or more was used as the criterion to remove the inde-
pendent variable from the models. Thus, we created three
models entering statistically significant socio-demographic
characteristics as independent variables in the first model,
adding significant clinical characteristics in the second
model and significant mental distress characteristics as
well as perceived social support in the third model.
The residual scatterplots were examined to check the
assumptions of normality, linearity and homoscedasticity
between the predicted dependent variable scores and er-
rors of prediction, and the assumptions were deemed to
be satisfied. Furthermore, the Durbin-Watson test statis-
tic expressed no correlation in adjacent residuals and the
variance inflation factor (VIF) and tolerance statistic in-
dicated no problem with multicollinearity.
The repeated measures analysis of variance (ANOVA)
was used to assess effect of Type D personality and
follow-up time on HRQoL with adjustment for potential
confounders, such as age, gender, NYHA class and acute
MI. For this task statistical analysis was performed only
patients participating in all monitoring phases over a
24 month period.
The changes in HRQoL during follow-up were assessed
by effect size, which is defined as the difference between
two means divided by a standard deviation for the data.
An effect size of 0.2 is considered a “small” effect; 0.5, a
“moderate” effect; and 0.8 to infinity, a “large” effect. Dif-
ferences in HRQoL between Type D and non-Type D per-
sonality patients at the beginning of cardiac rehabilitation
program (T1), after 6- (T6), 12- (T12), 18- (T18) and 24-
(T24) months and effect size, using T-test for independent
samples was estimated. Differences in HRQoL within
Type D and non-Type D patients groups over time be-
tween T1 and T6, T6 and T12 and T6 and T18, T6 and
T24, using T-test for dependent samples and estimation
magnitude of change with an effect size was performed.
Mediation analysis was used to examine whether mental
distress or perceived social support mediated the link be-
tween Type D personality and HRQoL after controlling
for covariates (gender, age, NYHA, acute MI) [43]. Ana-
lysis was performed following conditions that must be
fulfilled in order to establish mediation effect: first, the
predictor variable (Type D personality) must signifi-
cantly influence the mediator variable (anxiety symp-
toms, depressive symptoms or social support); second,the predictor variable must significantly influence the out-
come variable HRQoL and third, the predictor variable’s
influence on the outcome variable must be reduced or be-
come non-significant when the mediator variable is in-
cluded in the model. To test significance of the indirect
path via the mediator variable, we used Sobel’s test apply-
ing a utility provided by Preacher and Leonardelli [44].
Data was analyzed with the SPSS 17.0 for Windows
(Chicago, IL). Data are presented as mean ± standard de-
viation for continuous variables and as the number (per-
cent) for categorical variables.
Results
Baseline characteristics
There were no differences between participants who were
interviewed vs. those who were not interviewed (i.e., those
whom we were unable to contact, who had refused, or
who were excluded at the interview) on basic clinical and
demographic characteristics. We conducted a series of t
test comparisons using the clinical information obtained
during the screen of the electronic medical record on be-
half of providers. We found no significant differences in
age, number of comorbid conditions and minimum LVEF
(of those values in the clinical record) between those
interviewed and those who were not interviewed (all
p values > 0.05).
In short, the majority of studied patients (80%) had
hypertension: grade 1 (mild) 6.4%, grade 2 (moderate)
64.2%, grade 3 (severe) – 9.4%. Twenty eight percent had
angina pectoris, 59% – experienced an acute MI, 13% –
had a past history of MI. Six percent of patients were
classified NYHA functional class I, 77% – NYHA class
II and 17% – NYHA class III, there were no patients
classified as NYHA IV class in this study. Majority of
study patients 688 (86%) had normal to mild systolic
dysfunction (LVEF > 40%) and 112 (14%) had moderate to
severe systolic dysfunction (LVEF ≤ 40%). The prevalence
of patients with moderate-severe depressive (HADS-D
score ≥ 8) and anxiety (HADS-A score ≥ 8) symptoms was
13% and 33%, respectively, within the study population.
The prevalence of patients with Type D personality
was 33.5%. Clinical, demographic, mental distress and
HRQoL characteristics of patients, stratified by Type D
personality, are presented in Table 1. Type D personality
patients were more likely to be female, have a greater
NYHA class, have more anxiety and depressive symp-
toms, have a lack of social support and have decreased
HRQoL compared to non-Type D patients.
Associations among Type D personality, clinical
characteristics, mental distress, social support, and HRQoL
Univariate linear regression analyses showed that Type D
personality was associated with more anxiety symptoms
(β = 0.41, p < 0.001), more depressive symptoms (β = 0.42,
Table 1 Characteristics of all patients at inclusion stratified by Type D personality
All patients Type D Non Type D P value Difference between
proportions, %(n = 855) (n = 286) (n = 569)
Age, years (mean ± SD) 58.6 ± 8.8 58.6 ± 8.8 57.9 ± 9.0 0.304
Gender, n (%) <0.001
Men 633 (74.0) 182 (63.6) 451 (79.3) <0.001 15.6%
Women 222 (26.0) 104 (36.4) 118 (20.7) 0.010
Marital status, n (%) 0.336
Living with a partner 697 (81.5) 228 (79.7) 469 (82.4) 0.389 2.7%
Living alone 158 (18.5) 58 (20.3) 100 (17.6) 0.675
Diagnosis, n (%) 0.669
Angina pectoris 240 (28.1) 83 (28.9) 157 (27.5) 0.667 1.4%
Acute myocardial infarction 506 (59.2) 169 (59.1) 337 (59.2) 0.978 0.1%
Previous myocardial infarction 109 (12.7) 34 (11.9) 75 (13.2) 0.591 1.3%
Hypertension, n (%) 0.109
Grade 1 (mild) 55 (6.4) 18 (6.3) 37 (6.5) 0.911 0.2%
Grade 2 (moderate) 549 (64.2) 194 (67.8) 355 (62.4) 0.121 5.4%
Grade 3 (severe) 80 (9.4) 23 (8.0) 57 (10.0) 0.343 0.2%
NYHA class, n (%) 0.027
I 52 (6.1) 17 (5.9) 35 (6.2) 0.863 0.2%
II 659 (77.1) 207 (72.4) 452 (79.4) 0.022 7.1%
III 144 (16.8) 62 (21.7) 82 (14.4) 0.007 7.3%
Mental distress
HADS-A≥ 8, n(%) 281 (32.9) 164 (57.3) 117 (20.6) <.001 36.8%
HADS-D≥ 8, n(%) 112 (13.1) 82 (28.7) 30 (5.3) <.001 23.4%
Perceived social support, mean score ± SD 6.1 ± 1.0 5.9 ± 1.1 6.2 ± 0.9 <.001
Minnesota Living with heart failure questionnaire, mean score ± SD 31.7 ± 20.0 40.3 ± 19.6 27.3 ± 18.8 <.001
NYHA – New York Heart Association; HADS-D - Hospital Anxiety and Depression scale depression subscale; HADS-A - Hospital Anxiety and Depression scale
anxiety subscale.
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p < 0.001) (data not shown).
However, presence of Type D personality, and greater
anxiety and depressive symptom severity were signifi-
cantly associated with worse HRQoL, following adjust-
ment for socio-demographic and clinical characteristics
(Table 2). In addition, older age, female gender, more se-
vere NYHA class, and acute MI were each associated
with worse HRQoL.
HRQoL changes two years follow-up
The dynamic of quality of live over 2-years period in
Type D personality patients and non-Type D personality
patients is showed in Figure 2. During the period from
baseline to 6 month follow greater improvement of
HRQoL was documented in Type D than non-Type D
patients (effect sizes from T1 to T6 at levels of 0.63 and
0.24, respectively) (Table 3). The same pattern was ob-
served comparing Type D and non-Type D patients’ re-
sults in HRQoL in all phases of the two year follow-up(from T6 to T18 effect sizes of -0.12 and -0.07 respect-
ively; from T6 to T18 effect sizes of -0.24 and -0.14 re-
spectively; and from T6 to T24 effect sizes of -0.30
vs -0.21, respectively). However, in Type D personality
patients HRQoL remained worse over all follow-up
periods when comparing with non-Type D patients
(Tables 3 and 4).
The repeated measures analysis of variance showed, that
Type D personality was a significant independent deter-
minant of HRQoL F(1.426) = 4.00; p = 0.046), adjusting for
gender, age and NYHA class, acute MI. In the adjusted
analysis, the within-subjects effect for time was not signifi-
cant F(1.426) = 4.00; p = 0.463), indicating Type D and
Non-Type D personality patient groups do not change in
HRQoL over time Thus, Type D personality exerted a
stable effect on HRQoL over time.
Mental distress and social support as mediators
The predictor variable (Type D personality) significantly
influenced the proposed mediators (anxiety, depressive
Table 2 Mental distress and social support as determinants of health-related quality of life
Health related quality of life Depressive symptoms Anxiety symptoms Social support
β β β β
Model 1 R2 0.07*** 0.07*** 0.09*** 0.02**
ΔR2 0.07*** 0.07*** 0.09*** 0.02**
Age 0.08 0.15*** -0.03 -0.07*
Gender 0.26*** 0.20*** 0.31*** -0.09*
Model 2 R2 0.11*** 0.08*** 0.11*** 0.02**
ΔR2 0.04*** 0.01* 0.02** 0.001
Age -0.11** 0.12*** -0.06 -0.08*
Gender 0.24*** 0.18*** 0.29*** -0.09*
Acute MI -0.15*** -0.02 -0.07 0.00
NYHA 0.17*** 0.10** 0.12** 0.04
Model 3 R2 0.30*** 0.46*** 0.43*** 0.09***
ΔR2 0.19*** 0.38*** 0.32*** 0.07***
Age -0.13*** 0.14*** -0.12*** -0.04
Gender 0.12*** -0.01 0.18*** -0.04
Acute myocardial infarction -0.13*** 0.01 -0.05* -0.01
NYHA 0.11*** 0.03 0.06* 0.06
Anxiety symptoms 0.20*** 0.48*** – 0.02
Depressive symptoms 0.25*** – 0.50*** -0.27***
Social support -0.04 -0.16*** 0.01 –
Type D personality 0.09* 0.21*** 0.16*** -0.03
*p value < 0.05; **p value < 0.01; ***p value < 0.001; NYHA – New York Heart Association functional class.
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model. For anxiety symptoms the unstandardized re-
gression coefficient Ba was 2.888 (p < 0.001, standard
error SE = 0.242); for depressive symptoms Ba = 2.641




Baseline 6 months 12 months 18 months 24 months
Type D personality
Non Type D personality
Figure 2 Minnesota Living with heart failure global score
stratified by Type D personality over two years.(p < 0.001, SE = 0.076). The coefficients used for testing
mediation are also shown in Figure 3.
The predictor variable Type D personality significantly
influenced the outcome variable HRQoL (step 1 in
Table 5); the unstandardized coefficient Bc was 11.285
(p < 0.001, SE = 1.349). When adding the possible medi-
ator anxiety symptoms to the linear regression model
(step 2 in Table 5), the HRQoL coefficient decreased sig-
nificantly to Bc’ = 6.185 (SE = 1.382) suggesting medi-
ation effect. Anxiety symptoms significantly influenced
HRQoL with a coefficient Bb of 2.065 (p < 0.001, SE =
0.169). The indirect pathway was significant at p < 0.001,
based on Sobel’s test.
The same analysis was done using depressive symp-
toms as mediator variable. Again, the predictor variable
significantly influenced HRQoL (step 1 in Table 5). After
adding depressive symptoms to the model, the unstan-
dardized coefficient decreased to Bc’ = 5.014 (p < 0.001,
SE = 1.391) (step 2 in Table 5). Depressive symptoms still
exerted significant influence on the HRQoL with a coef-
ficient Bb = 2.695 (p < 0.001, SE = 0.201). The indirect
path was significant at p < 0.001, according to Sobel’s
test.
The last analysis included social support as mediator
variable. As in previous models Type D personality
Table 3 Differences of HRQoL and effect sizes (ES) between separate follow-up periods
Health related quality of life Type D personality Non-Type D personality
Mean ± SD p ES(d) Mean ± SD p ES(d)Periods
T1 Baseline 42.45 ± 19.78 <0.001 .63 28.84 ± 19.08 <0.001 0.24
T6 6 month 31.96 ± 16.52 24.40 ± 14.13
T6 6 months 31.96 ± 16.52 0.255 -0.12 24.40 ± 14.13 0.162 -0.07
T12 12 month 33.27 ± 17.59 25.49 ± 15.04
T6 6 months 31.96 ± 16.52 0.006 -0.24 24.40 ± 14.13 0.010 -0.14
T18 18 month 35.68 ± 17.54 26.45 ± 14.66
T6 6 months 31.96 ± 16.52 0.002 -0.30 24.40 ± 14.13 0.001 -0.21
T24 24 month 36.05 ± 17.10 27.33 ± 14.73
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ing social support to the model (step 2 in Table 5), the
HRQoL coefficient decreased significantly to Bc’ = 10.612
(SE = 1.353) suggesting mediation effect. Social support
significantly influenced HRQoL Bb = −2.867 (p < 0.001,
SE = 0.632). The indirect path was significant at p <
0.001, according to Sobel’s test.
Assessment of overall strength of our regression model
showed that the addition of the mediator variables anx-
iety symptoms, depressive symptoms and social support
to the independently generated model greatly increased
R2: when using anxiety symptoms as mediator, R2 in-
creased from 0.243 to 0.261; for depressive symptoms,
R2 increased from 0.267 to 0.278; and when using social
support, R2 increased from 0.129 to 0.189 (Table 5).
Discussion
In CAD patients with heart failure undergoing rehabili-
tation and during a two year follow-up, Type D person-
ality was significantly associated with impaired HRQoL,
independent from age, gender and disease severity. In
addition, the present results may provide information re-
garding the mechanisms underlying this association.
Specifically, our findings indicate that mental distress
and perceived social support may partially account for
the relation between Type D personality and HRQoL.
Our findings showed that one third of CAD patients
with heart failure were classified as having a Type D per-
sonality. Given the fact that these individuals have a sig-
nificantly impaired quality of life, it is very important toTable 4 Differences of HRQoL and effect sizes during follow-u
Health related quality of life Type D personality
Mean ± SD
Baseline 42.45 ± 19.78
6 months 31.96 ± 16.52
12 months 33.27 ± 17.59
18 months 35.68 ± 17.54
24 months 36.05 ± 17.10establish modifiable factors that may have impact on
Type D personality.
Previous studies exploring the association of Type D
personality with HRQoL in cardiac patients also have
shown that Type D personality is associated with impaired
HRQoL, after adjusting for potential confounders related
to HRQoL, including depressive symptoms [21,45-47].
One possible explanation for why Type D personality
patients had a decreased HRQoL may be that Type D
personality patients are at higher risk for poor medica-
tion adherence, which may lead to adverse health out-
comes [48]. Type D personality carries an increased risk
of mental disorders, such as depression [21], and symp-
toms of anxiety [23], thereby, increasing the emotional
burden of CAD.
In this study Type D personality was consistently associ-
ated with impaired HRQoL over the period of 24 months.
In previous studies [16,21,45] similar findings were found,
however the follow up periods were shorter in duration:
from 9 to 12 months. Thus, the current study extends the
findings of these studies by showing that Type D personal-
ity had a stable effect over a longer 24-months period.
To the extent of our knowledge, there are no studies that
examined Type D personality mediating factors in CAD
patients with heart failure. One study examined HRQoL in
coronary artery bypass graft surgery patients 6 months after
operation and found that increased levels of anxiety largely
mediated the influence of Type D personality on no change
deterioration in HRQoL, whereas increased symptoms of
depression explained deterioration in HRQoL without thep periods
Non-type D personality P ES(d)
Mean ± SD
28.84 ± 19.08 <0.001 0.74
24.40 ± 14.13 <0.001 0.47
25.49 ± 15.04 <.001 0.50
26.45 ± 14.66 <0.001 0.58


































Figure 3 Relation between Type D personality, possible mediators and health related quality of life. a) Mediation model relating Type D
personality, anxiety, and health related quality of life. b) Mediation model relating Type D personality, depression, and health related quality of life.
c) Mediation model relating Type D personality, social support, and health related quality of life.
Staniute et al. Health and Quality of Life Outcomes  (2015) 13:1 Page 9 of 11influence of Type D personality [45]. A cross-sectional study
of tinnitus patients found that Type D personality was also a
direct predictor of decreased HRQoL and this influence was
mainly mediated by symptoms of depression and anxiety
[47]. The present study, showed similar results that Type D
personality remains significant determinant of impaired
HRQoL with both mediating mental distress factors.
Social support is a known buffer of psychological distress,
our study results showed that perceived social support also
mediates the relationship between Type D personality and
HRQoL. It is important to note that support perceptions
(perceived support) and receipt of supportive behaviors
(received support) are different characteristics. According
to meta-analytical review only perceived support, but not
received support, has been linked to health-relatedTable 5 Mental distress and social support as mediators of t
health-related quality of life
Health related quality of life (outco
Step 1
B [95%-CI] β
Type D personality (predictor) 11.285[8.638;13.933] 0.267***
Anxiety symptoms (mediator) 2.065[1.733;2.397] 0.389***
Depressive symptoms (mediator) 2.695[2.302;3.089] 0.415***
Social support (mediator) 2.867[−4.107;−1.627] −0.148***
***p value < .001.outcomes [49]. What is more patients with lower perceived
social support tend to be more depressed [50] and anxious
[51]. Symptoms of depression and anxiety may inhibit Type
D personality characteristics leading to decrease in HRQoL
later on [52]. On the other way round anxiety and depres-
sion in Type D personality patients make them avoid
expressing appropriate and timely emotions. Avoiding
express emotions can reduce the quality of interpersonal
relationships and HRQoL. Our findings add to the know-
ledge of perceived social support being mediator between
Type D personality and HRQoL. Whether this particular
effect is the same in other types of support, such as received
social support, is unknown.
However our results with regards to mediation effect
should be interpreted with caution. Type D personalityhe relationship between Type D personality and
me)
Step 2
Type D personality (predictor) x mediator
R2 B [95%-CI] β R2
0.177
0.243 1.758[1.403;2.113] 0.331*** 0.261
0.267 2.365[1.935;2.796] 0.036*** 0.278
0.129 −2.192[−3.401;−0.982] −0.113*** 0.189
Staniute et al. Health and Quality of Life Outcomes  (2015) 13:1 Page 10 of 11influence on HRQoL was significant, but only slightly
reduced when anxiety symptoms and social support (but
not depression symptoms) were included in the models.
This often suggests evidence of the effects of one or
more omitted mediators. It could be also interpreted as
a sign of some as-yet-undiscovered mediation mechan-
ism [53] e.g. specific illness perceptions [54].
As to test this hypothesis was beyond the scope of our
aims, future studies regarding mechanisms responsible
for the relationship between Type D personality and
HRQoL are warranted.
Type D personality patients deserve special attention
during the period of rehabilitation as it was shown that
Type D personality independently predicts a decreased
HRQoL. Rehabilitation offers an excellent opportunity
for the identification of mental distress and the opportun-
ities for psychological interventions, such as depression
and anxiety management. Expanded cardiac rehabilitation
reduces Type D score, anxiety and depressive symptoms
and improves the quality of life [55].
The findings of this study should be interpreted with
some caution, in terms of generalizability, as the major-
ity of study CAD patients had mild to moderate heart
failure and all study patients attended cardiac rehabilita-
tion program. Thus, the results may not apply to pa-
tients with more advanced heart failure and those who
do not attend cardiac rehabilitation programs. Further-
more, lack of more comprehensive assessment of mental
health status precluded from more rigorous assessment
of mental status dynamics of CAD patients. On the
other hand, the major strengths of our study include a
large sample size, longitudinal observational study de-
sign and the use of reliable and valid measures.
Conclusions
The present study demonstrated that Type D personality
CAD patients with heart failure reported impaired
HRQoL, during phase II cardiac rehabilitation and two
years follow-up. Depressive, anxiety symptoms and
perceived social support may mediate this association.
For this reason, when planning cardiac rehabilitation
programs vulnerable patients, such as those with Type D
personality should be targeted for psychological inter-
vention with the aims of improving HRQoL.
Abbreviation
CAD: Coronary artery disease; HRQoL: Health-related quality of life; NYHA: New
York Heart Association; DS14: Type D personality scale; NA: Negative affectivity;
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Questionnaire; HADS: Hospital Anxiety and Depression scale; HADS-A: Hospital
Anxiety and Depression scale anxiety subscale; HADS-D: Hospital Anxiety and
Depression scale depression subscale; MSPSS: Multidimensional Scale of
Perceived Social Support.
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